• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Molecular and Epidemiological analysis of Pandemic and Post-pandemic Influenza A(H1N1)pdm09 virus from central India

tetano

Editor, Senior Moderator
J Med Virol. 2017 Oct 26. doi: 10.1002/jmv.24982. [Epub ahead of print]
[h=1]Molecular and Epidemiological analysis of Pandemic and Post-pandemic Influenza A(H1N1)pdm09 virus from central India.[/h] Sahu M[SUP]1[/SUP], Singh N[SUP]1[/SUP], Shukla MK[SUP]1[/SUP], Potdar VA[SUP]2[/SUP], Sharma RK[SUP]1[/SUP], Sahare LK[SUP]1[/SUP], Ukey MJ[SUP]1[/SUP], Barde PV[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza A(H1N1)pdm09 virus pandemic struck India in 2009 and continues to cause outbreaks in its post pandemic phase. Diminutive information is available about influenza A(H1N1)pdm09 from central India. This observational study presents epidemiological and molecular findings for the period of six years. Throat swab samples referred from districts of Madhya Pradesh were subjected to diagnosis of Influenza A(H1N1)pdm09 following WHO guidelines. Clinical and epidemiological data was recorded and analysed. Hemagglutinin (HA) gene sequencing and phylogenetic analysis was performed. The H275Y mutation responsible for antiviral resistance was tested using allelic real time RT-PCR. Out of 7365 tested samples 2406 (32.7%) were positive for Influenza A(H1N1)pdm09 of which 363 (15.08%) succumbed to infection. Significant trends was observed in positivity (x[SUP]2[/SUP] = 50.8; p<0.001) and mortality (x[SUP]2[/SUP] = 24.4; p<0.001) with increasing age. Mutations having clinical and epidemiological importance were detected. Phylogenetic analysis of HA gene sequences revealed that clade 7, 6 A and 6B viruses were in circulation. Oseltamivir resistance was detected in three fatal cases. Influenza A(H1N1)pdm09 viruses having genetic diversity were detected from central India and continues to be a concern for public health. Study highlights the need of year-round monitoring by establishment of strong molecular and clinical surveillance program. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.


[h=4]KEYWORDS:[/h] Central India; Epidemiology; Influenza A(H1N1)pdm09; Mutations; Phylogenetic analysis

PMID: 29073730 DOI: 10.1002/jmv.24982
 
Back
Top Bottom